Battling antibiotic-resistant superbugs calls for new and more advanced ways of detecting them and treating patients. Because greater reimbursement payments are tied to preventing healthcare-associated infections (HAIs), Sentri7 allows infection prevention teams to detect infections and trends sooner, so they can impact patient care and prevent a single case from becoming an outbreak.
Sentri7 automates and standardizes surveillance and reporting, providing more time for valuable infection prevention responsibilities.
Sentri7 delivers advanced clinical decision support through highly-sensitive automated patient alerts, information on prescribing patterns and overall drug usage, real-time alerts on high-risk drugs and dangerous interactions and continuous monitoring of the patient population. It supports investigation of HAIs, isolation management and compliance with federal and state reporting requirements.
Recognizing that speed and accuracy are crucial in reducing the spread of infection, Sentri7’s intuitive alerts are built on evidence that minimizes false alerts, delivers more specific contextual rules tailored to user and type of workflow and allows clinicians to act fast and early. So, they can identify patients with potential or confirmed communicable diseases through automated flagging of specific diagnoses, drug orders, laboratory findings or culture results.
Sentri7 directly sends validated data to NHSN through one-click reporting. It stays current with NHSH changes, so your hospital doesn’t need to manually incorporate revisions or updates to NHSN guidelines.
Learn how multiple infection prevention teams use Sentri7 to support their workflows.